Long-term efficacy of pravastatin therapy in diabetic patients undergoing complete coronary revascularization

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 4, 2010, Pages 350-355

  Aihara, Kouichiro ^a   Miyauchi, Katsumi ^a   Kasai, Takatoshi ^a   Kubota, Naozumi ^a   Kajimoto, Kan ^a   Tamura, Hiroshi ^a   Kojima, Takahiko ^a   Yokoyama, Ken ^a   Kurata, Takeshi ^a   Amano, Atsushi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Coronary intervention; Diabetes; Long term follow up; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; NICORANDIL; ORAL ANTIDIABETIC AGENT; PRAVASTATIN;

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETIC PATIENT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RISK REDUCTION;

EID: 77953502766     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.1925     Document Type: Article

References (16)

1. Coronary Angioplasty in Diabetic Patients: The National Heart, Lung, and Blood Institute Percutaneous Translu-minal Coronary Angioplasty Registry Kevin E. Kip, David P. Faxon, Katherine M. Detre, Wanlin Yeh, Sheryl F. Kelsey, and Jesse W. Currier Circulation, 1996; 94: 1818-1825
2. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008; 358: 2545-2559
3. The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med, 2008; 358: 2560-2572.
4. Huxley R, Barzi F, Woodward M: Excess risk of fatal coro-nary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ, 2006; 332: 73-76
5. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med, 2008; 358: 580-591
6. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: pro-spective meta-analysis of data from 90056 participants in 14 randomised trials of statins. The Lancet, 2005; 366: 1267-1278
7. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y and for the MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospec-tive randomised controlled trial The Lancet, 2006; 368: 1155-1163
8. Tomohiro Sakamoto, Sunao Kojima, Hisao Ogawa, Hideki Shimomura, Kazuo Kimura, Yasuhiro Ogata, Naritsugu Sakaino, and Akira Kitagawa, on behalf of the Multi-center Study for Aggressive Lipid-Lowering Strategy by HMG-CoA Reductase Inhibitors in Patients With Acute Myocardial Infarction (MUSASHI-AMI) Investigators. Effects of Early Statin Treatment on Symptomatic Heart Failure and Ischemic Events After Acute Myocardial Infarction in Japanese. Am J Cardiol, 2006; 97: 1165-1171
9. Ogilvie RI, Anand S, Roy P, De Souza S; PEACH investi-gators. Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study. Clin Drug Investig, 2008; 28: 673-686
10. Fedoruk LM, Wang H, Conaway MR, Kron IL, Johnston KC: Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg, 2008; 85: 1521-1525.
11. Papathanasiou A, Toumpoulis IK, Milionis HJ, Kalantzi K, Katsouras CS, Goudevenos J: Statin therapy is associated with reduced total and cardiovascular mortality after coro-nary artery bypass grafting surgery. Coron Artery Dis, 2008; 19: 619-625
12. Michitaka Nagashima, Ryo Koyanagi, Hiroshi Kasanuki, Nobuhisa Hagiwara, Jun-ichi Yamaguchi, Nobuhiko Atsuchi, Takashi Honda, Kazuo Haze, Tetsuya Sumiyoshi, Mitsuyoshi Urashima, Hiroshi Ogawa and Heart Institute of Japan Department of Cardiology (HIJC) Investigators. Effect of Early Statin Treatment at Standard Doses on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction (The Heart Institute of Japan, Department of Cardiology Statin Evaluation Program). Am J Cardiol, 2007; 99: 1523-1528
13. Kasai T, Miyauchi K, Kurata T, Satoh H, Ohta H, Tani-moto K, Kawamura M, Okazaki S, Yokoyama K, Kojima T, Akimoto Y, Daida H Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy. Int J Cardiol, 2007; 114: 210-217.
14. Primary prevention of cardiovascular disease with atorvas-tatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised pla-cebo-controlled trial.Colhoun HM, Betteridge DJ, Dur-rington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators. Lancet, 2004 Aug 21-27; 364 (9435): 685-696
15. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis, 2008; 371: 117-125
16. Shah BR, Laupacis A, Hux JE, Austin PC: Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol, 2005; 58: 550-559.